Hypercalcemia may develop in patients with osteoporosis and treated with recombinant PTH (1‐84), and serum calcium correlates with urinary calcium excretion, serum ALP, and β‐CTX in these patients.25 This evidence concerns the gene PTH and hypercalcemia disease.